Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 351 to 400 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synbindin (trs23 homolog) (hematopoietic stem/progenitor cell protein 172) (hspc172) (ptd009) (cgi-104). [source:swissprot;acc:q9y296]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
17396.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
20483.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17745\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bet3 homolog. [source:swissprot;acc:o43617]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p66 alpha. [source:refseq;acc:nm\_017660]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
12839\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
10911.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17669\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription repressor p66 beta component of the mecp1 complex. [source:refseq;acc:nm\_020699]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine aminotransferase (ec 2.6.1.5) (l-tyrosine:2-oxoglutarate aminotransferase) (tat). [source:swissprot;acc:p17735]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, alpha subunit (tcp-1-alpha) (cct-alpha). [source:swissprot;acc:p17987]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11004.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12944.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1763\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
imp2 inner mitochondrial membrane protease-like; inner mitochondrial membrane peptidase 2 like. [source:refseq;acc:nm\_032549]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5061.11\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5950.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17567\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microsomal signal peptidase 18 kda subunit (ec 3.4.-.-) (spase 18 kda subunit) (spc18) (endopeptidase sp18). [source:swissprot;acc:p21378]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 3 (ec 2.7.1.-). [source:swissprot;acc:q00526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12798.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10887.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17559\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12796.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10886\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 2 (ec 2.7.1.-) (p33 protein kinase). [source:swissprot;acc:p24941]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12787.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10880.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17528\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b1. [source:swissprot;acc:p14635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12786.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10879.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17525\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division control protein 2 homolog (ec 2.7.1.-) (p34 protein kinase) (cyclin-dependent kinase 1) (cdk1). [source:swissprot;acc:p06493]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12780.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10876.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17509\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5189\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
crooked neck-like protein 1 (crooked neck homolog) (hcrn) (cgi-201) (mstp021). [source:swissprot;acc:q9bzj0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon, catalytic subunit a (ec 2.7.7.7) (dna polymerase ii subunit a). [source:swissprot;acc:q07864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4024.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4719.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna splicing factor prp17 (hprp17) (eh-binding protein 3) (ehb3). [source:swissprot;acc:o60508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5082.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5959.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17261\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-box-binding transcription factor (ccaat-binding factor) (cbf). [source:swissprot;acc:q03701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3583.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4194.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4108.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4808.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17058\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra2, mitochondrial precursor (ec 3.4.21.-) (high temperature requirement protein a2) (htra2) (omi stress-regulated endoprotease) (serine proteinase omi). [source:swissprot;acc:o43464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5067.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16961\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5067\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16956\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5066.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5926.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16955\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5066.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5925.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm1 (small nuclear ribonuclear casm) (cancer-associated sm-like). [source:swissprot;acc:o15116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4700.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5492.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16854\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
44050 protein. [source:refseq;acc:nm\_178832]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
17385.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
14889.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16769\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear inhibitor of protein phosphatase-1 (nipp-1) (protein phosphatase 1, regulatory inhibitor subunit 8) [includes: activator of rna decay (ec 3.1.4.-) (ard-1)]. [source:swissprot;acc:q12972]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12471.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14561.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16758\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6704.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7811.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, very-long-chain specific, mitochondrial precursor (ec 1.3.99.-) (vlcad). [source:swissprot;acc:p49748]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12998.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15138.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16461\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5246.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6109.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16456\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
parkinson disease (autosomal recessive, juvenile) 2, parkin isoform 1; parkin. [source:refseq;acc:nm\_004562]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor-related protein 2. [source:refseq;acc:nm\_032631]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgi-142; hepatoma-derived growth factor 2. [source:refseq;acc:nm\_016073]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l8. [source:swissprot;acc:p25120]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatoma-derived growth factor (hdgf) (high-mobility group protein 1- like 2) (hmg-1l2). [source:swissprot;acc:p51858]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pwwp domain containing 1; hdgf (hepatoma-derived growth factor) like. [source:refseq;acc:nm\_138574]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent rna helicase p54 (oncogene rck) (dead-box protein 6). [source:swissprot;acc:p26196]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rw1 protein (fragment). [source:swissprot;acc:q92545]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tar dna-binding protein-43 (tdp-43). [source:swissprot;acc:q13148]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3658.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3144.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16358\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent rna helicase mgc2835; atp-dependent rna helicase; apoptosis related protein apr-5; dead box helicase 97 kda. [source:refseq;acc:nm\_024072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3641.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4236.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16339\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4e (eif-4e) (eif4e) (mrna cap-binding protein) (eif-4f 25 kda subunit). [source:swissprot;acc:p06730]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4490.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5222.25\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16301\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bai1-associated protein 3; bai-associated protein 3. [source:refseq;acc:nm\_003933]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 4 isoform b; rna-binding protein. [source:refseq;acc:nm\_021164]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4532.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5269.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16251\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleotide reductase m2 b (tp53 inducible); p53-inducible ribonucleotide reductase small subunit 2 homolog. [source:refseq;acc:nm\_015713]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6563.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7627.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16205\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear protein skip (ski-interacting protein) (snw1 protein) (nuclear receptor coactivator ncoa-62). [source:swissprot;acc:q13573]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5367.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6233.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16137\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xpa-binding protein 2 (hcnp protein) (pp3898). [source:swissprot;acc:q9hcs7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5084.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5904.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-7 chain precursor. [source:swissprot;acc:p36544]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type vi (ec 4.6.1.1) (atp pyrophosphate-lyase) (ca(2+)-inhibitable adenylyl cyclase). [source:swissprot;acc:o43306]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/